124 related articles for article (PubMed ID: 35088662)
1. Natural Products Against COVID-19 Inflammation: A Mini-Review.
Lopes SM; de Medeiros HIR; Scotti MT; Scotti L
Comb Chem High Throughput Screen; 2022; 25(14):2358-2369. PubMed ID: 35088662
[TBL] [Abstract][Full Text] [Related]
2. Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.
Zhao Y; Deng S; Bai Y; Guo J; Kai G; Huang X; Jia X
Phytother Res; 2022 Oct; 36(10):3833-3858. PubMed ID: 35932157
[TBL] [Abstract][Full Text] [Related]
3. Targeting Natural Products for the Treatment of COVID-19 - An Updated Review.
Pamuru RR; Ponneri N; Damu AG; Vadde R
Curr Pharm Des; 2020; 26(41):5278-5285. PubMed ID: 32881659
[TBL] [Abstract][Full Text] [Related]
4. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.
Llivisaca-Contreras SA; Naranjo-Morán J; Pino-Acosta A; Pieters L; Vanden Berghe W; Manzano P; Vargas-Pérez J; León-Tamariz F; Cevallos-Cevallos JM
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279439
[TBL] [Abstract][Full Text] [Related]
5. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.
Shawon J; Akter Z; Hossen MM; Akter Y; Sayeed A; Junaid M; Afrose SS; Khan MA
Curr Pharm Des; 2020; 26(41):5241-5260. PubMed ID: 33155902
[TBL] [Abstract][Full Text] [Related]
6. Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19.
Thota SM; Balan V; Sivaramakrishnan V
Phytother Res; 2020 Dec; 34(12):3148-3167. PubMed ID: 32881214
[TBL] [Abstract][Full Text] [Related]
7. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease.
Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO
J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801
[TBL] [Abstract][Full Text] [Related]
8. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.
Lee M; Park J; Cho IH
Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089
[TBL] [Abstract][Full Text] [Related]
9. Targeting natural products against SARS-CoV-2.
Al-Harrasi A; Behl T; Upadhyay T; Chigurupati S; Bhatt S; Sehgal A; Bhatia S; Singh S; Sharma N; Vijayabalan S; Palanimuthu VR; Das S; Kaur R; Aleya L; Bungau S
Environ Sci Pollut Res Int; 2022 Jun; 29(28):42404-42432. PubMed ID: 35362883
[TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
Ye ZW; Jin DY
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
[TBL] [Abstract][Full Text] [Related]
12. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
13. Natural Substances and Semisynthetic Derivatives as Potential Alternative Products Against SARS-CoV-2.
Fuochi V; Furneri PM
Mini Rev Med Chem; 2021; 21(13):1596-1611. PubMed ID: 33535950
[TBL] [Abstract][Full Text] [Related]
14. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review.
Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550
[TBL] [Abstract][Full Text] [Related]
15. Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19.
Jafari Porzani S; Konur O; Nowruzi B
J Biomol Struct Dyn; 2022 Oct; 40(16):7629-7644. PubMed ID: 33749496
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking and simulation studies of natural compounds of
Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
[TBL] [Abstract][Full Text] [Related]
17. [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
Yan CX; Li J; Shen X; Luo L; Li Y; Li MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):139-145. PubMed ID: 32220178
[TBL] [Abstract][Full Text] [Related]
18. Analyzing Citizens' and Health Care Professionals' Searches for Smell/Taste Disorders and Coronavirus in Finland During the COVID-19 Pandemic: Infodemiological Approach Using Database Logs.
Mukka M; Pesälä S; Hammer C; Mustonen P; Jormanainen V; Pelttari H; Kaila M; Helve O
JMIR Public Health Surveill; 2021 Dec; 7(12):e31961. PubMed ID: 34727525
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
Rana AK; Rahmatkar SN; Kumar A; Singh D
Cytokine Growth Factor Rev; 2021 Apr; 58():92-101. PubMed ID: 32948440
[TBL] [Abstract][Full Text] [Related]
20. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2.
da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP
Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
